Serum endothelin-1 and transforming growth factor-beta levels in the newborns with respiratory distress

Mediators Inflamm. 2006;2006(5):85432. doi: 10.1155/MI/2006/85432.

Abstract

The purpose of this present study was to evaluate the serum levels of ET-1 and TGF-beta in the newborns with respiratory distress. In this study, newborns with respiratory distress hospitalized into the Newborn Intensive Care Unit were included. The highest values of ET-1 and TGF-beta were obtained from newborns with diagnosis as meconium aspiration syndrome (5.70 +/- 5.87 pg/mL and 3.75 +/- 1.94 pg/mL, resp) in the sample obtained in the first six hours after birth, and these are statistically different from control group (P < .05). Also, same results were obtained for newborns with respiratory distress syndrome (3.37 +/- 1.59 pg/mL and 2.05 +/- 0.98 pg/mL, resp). After oxygen treatment, ET-1 values obtained in the first six hours of life were decreased regularly in the following days (P < .05). In the differentiating diagnosis of the respiratory distress of newborns, the investigation of ET-1 and TGF-beta levels is meaningful. The ET-1 levels investigated in the first six hours is more useful in determining the prognosis, and repeating ET-1 levels in the following days is more meaningful to determine clinical response.

MeSH terms

  • Case-Control Studies
  • Diagnosis, Differential
  • Endothelin-1 / blood*
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Premature
  • Inflammation Mediators / blood
  • Intensive Care Units, Neonatal
  • Male
  • Meconium Aspiration Syndrome / blood
  • Meconium Aspiration Syndrome / diagnosis
  • Respiratory Distress Syndrome, Newborn / blood*
  • Respiratory Distress Syndrome, Newborn / diagnosis
  • Transforming Growth Factor beta / blood*
  • Turkey

Substances

  • Endothelin-1
  • Inflammation Mediators
  • Transforming Growth Factor beta